HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bechara F. Akl Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akl, B. F. Articles by Richardson, G. Search for Related Content PubMed PubMed Citation Articles by Akl, B. F. Articles by Richardson, G.

Ann Thorac Surg 1980;29:109-112
© 1980 The Society of Thoracic Surgeons

---

Articles

Serum Cefazolin Levels during Cardiopulmonary Bypass

Department of Surgery, the University of New Mexico School of Medicine, and the Veterans Administration Hospital, Albuquerque, NM

Accepted for publication May 22, 1979.

^* Address reprint requests to Dr. Akl, Department of Surgery, University of New Mexico School of Medicine, Albuquerque, NM 87131

This study was done to assess the adequacy of a regimen using cefazolin as a prophylactic antibiotic for patients undergoing open-heart operation. At the time of the preoperative medication, adult patients received 1 gm of cefazolin intramuscularly, and pediatric patients were given a dose of 20 mg per kilogram of body weight. Group I consisted of 10 adults undergoing a variety of cardiac procedures. The mean serum cefazolin level after institution of cardiopulmonary bypass was 27.36 µg/ml (range, 13.1 to 40.3 µg/ml). This level remained fairly stable throughout cardiopulmonary bypass. Group II consisted of 10 pediatric patients undergoing cardiac procedures for repair of a variety of congenital anomalies. The mean serum cefazolin level after institution of cardiopulmonary bypass was 20.01 µg/ml (range, 11.4 to 28.9 µg/ml) and remained stable for the duration of the procedure. In both groups perfusion pressure, urinary output, and body temperature did not seem to have any influence on these levels.

It is concluded that the administration of one dose of cefazolin intramuscularly before operation results in an adequate and stable serum cefazolin level in patients undergoing cardiopulmonary bypass for up to three hours, possibly longer.

This article has been cited by other articles:

				M. H. Nguyen, S. J. Eells, J. Tan, C. T. Sheth, B. Omari, M. Flores, J. Wang, and L. G. Miller Prospective, Open-Label Investigation of the Pharmacokinetics of Daptomycin during Cardiopulmonary Bypass Surgery Antimicrob. Agents Chemother., June 1, 2011; 55(6): 2499 - 2505. [Abstract] [Full Text] [PDF]

				J.-J. Lehot Cefazolin prophylaxis during cardiac operations Ann. Thorac. Surg., February 1, 2004; 77(2): 755 - 756. [Full Text] [PDF]

				E. K. Fellinger, B. J. Leavitt, and J. C. Hebert Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery Ann. Thorac. Surg., October 1, 2002; 74(4): 1187 - 1190. [Abstract] [Full Text] [PDF]

				V. Lonsky, J. Mandak, V. Lonska, V. Rozsival, D. Markova, and J. Kubicek Serum oxacillin and cephazolin levels during cardiopulmonary bypass Perfusion, April 1, 1992; 7(2): 115 - 118. [Abstract] [PDF]